Original price was: $40.00.$34.00Current price is: $34.00.
Bremelanotide
Contents: 10mg of PT-141
Form: Lyophilized Powder
Emerging Research Evidence:
Researched for libido, sexual-response signaling, and brain-to-body communication pathways.
Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated
Batch-verified inventory. See 3rd Party COA.
In Stock — Order by 4 PM Central Time, ships today
Select quantity to unlock savings.
Note: Same-product quantities only. Not combinable with BOGO-style promotions. Eligible offers capped at 30% total savings.
Availability: Larger-volume orders are subject to current inventory.
⚠️ Requires Sterile Water for Reconstitution. Type may vary by formulation.
For laboratory use only.
PT-141 is a specialized research analog used to study centralized drive signals and intimate response pathways. Unlike traditional research tools that focus on local blood flow, PT-141 allows researchers to observe how the brain coordinates neuroendocrine signaling to trigger internal response mechanisms. Investigators use this peptide to map the pathways of systemic vitality and how the nervous system communicates desire-based signals within a controlled environment.
Researchers employ PT-141 to analyze how melanocortin receptor interactions influence the timing of “drive” signals and pathway coordination. By mapping these centralized signaling cascades, investigators gather technical data on how the brain manages biological attraction signals and maintains response agility at a molecular level.
Current studies focus on the mechanisms of signal-specificity and how neural pathways support internal vigor. This vial provides a robust technical framework for investigating the receptor-driven networks that govern the body’s natural response systems, offering a deeper look at molecular communication without focusing on clinical outcomes or performance enhancement.
CAS Number: 189691-06-3
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight (average): ~1025.18 g/mol
Monoisotopic Mass: 1024.5243 Da
Parent Compound:
Derived from melanocortin peptide analogs related to Melanotan II (MT-II), modified for research purposes.
PT-141 is utilized in pre-clinical research models across the following areas:
Melanocortin Receptor Signaling Research
Investigating MC3R and MC4R receptor activation, downstream signal transduction, and pathway coordination.
Neuroendocrine Signaling Dynamics
Studying melanocortin-associated signaling integration within central neuroendocrine research systems.
Receptor Binding & Signal Timing Studies
Examining ligand affinity, signaling duration, and intracellular cascade activation in laboratory environments.
Pathway Mapping & Signal-Specificity Analysis
Researching melanocortin pathway organization and receptor-mediated signaling regulation.
Biomarker Modulation in Experimental Models
Evaluating changes in signaling biomarkers associated with melanocortin receptor engagement under controlled conditions.
PT-141 is a specialized research analyte used to explore the pathways of centralized drive signals and neuroendocrine vigor. In laboratory settings, this peptide allows researchers to observe how molecular interactions coordinate intimate response signaling and maintain receptor-mediated harmony within the central nervous system. These exploratory studies focus on mapping the timing of internal attraction signals and how neural pathways support biological response agility, providing technical data on signaling behavior without any focus on sexual, behavioral, or therapeutic results.
PT-141 is intended for laboratory research use only. Not for human or veterinary consumption. Not approved by the FDA for therapeutic or diagnostic use. All referenced studies are pre-clinical and exploratory.
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
